A
Adriana K. Malone
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 41
Citations - 1135
Adriana K. Malone is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 16, co-authored 40 publications receiving 823 citations. Previous affiliations of Adriana K. Malone include Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
Secondary solid cancer screening following hematopoietic cell transplantation.
Y. Inamoto,Nirali N. Shah,Bipin N. Savani,Bronwen E. Shaw,Allistair Abraham,Ibrahim Ahmed,G. Akpek,Yoshiko Atsuta,K. S. Baker,Grzegorz W. Basak,Menachem Bitan,Zachariah DeFilipp,T. K. Gregory,Hildegard T. Greinix,Mehdi Hamadani,Betty K. Hamilton,Robert J. Hayashi,David A. Jacobsohn,R. T. Kamble,Kimberly A. Kasow,Nandita Khera,Hillard M. Lazarus,Adriana K. Malone,Maria Teresa Lupo-Stanghellini,Steven P. Margossian,Lori Muffly,Maxim Norkin,Muthalagu Ramanathan,Nina Salooja,Hélène Schoemans,John R. Wingard,Baldeep Wirk,William A. Wood,Agnes S. M. Yong,Christine Duncan,Mary E.D. Flowers,Navneet S. Majhail +36 more
TL;DR: All HCT recipients should be advised of the risks of secondary cancers annually and encouraged to undergo recommended screening based on their predisposition and proposed guidelines to help clinicians in providing screening and preventive care for secondary cancers among HCT recipient are proposed.
Journal ArticleDOI
Reduced-Intensity Hematopoietic Cell Transplantation for Patients with Primary Myelofibrosis: A Cohort Analysis from the Center for International Blood and Marrow Transplant Research
Vikas Gupta,Adriana K. Malone,Parameswaran Hari,Kwang Woo Ahn,Zhen-Huan Hu,Robert Peter Gale,Karen K. Ballen,Mehdi Hamadani,Eduardo Olavarria,Aaron T. Gerds,Edmund K. Waller,Luciano J. Costa,Joseph H. Antin,Rammurti T. Kamble,Koen M. Van Besien,Bipin N. Savani,Harry C. Schouten,Jeff Szer,Jean-Yves Cahn,Marcos de Lima,Baldeep Wirk,Mahmoud Aljurf,Uday R. Popat,Nelli Bejanyan,Mark R. Litzow,Maxim Norkin,Ian D. Lewis,Gregory A. Hale,Ann E. Woolfrey,Alan M. Miller,Celalettin Ustun,Madan Jagasia,Michael Lill,Richard T. Maziarz,Jorge E. Cortes,Matt Kalaycio,Wael Saber +36 more
TL;DR: The data indicate that RIC HCT is a potentially curative option for patients with MF, and that donor type is the most important factor influencing survival in these patients.
Journal ArticleDOI
KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results.
Bijal D. Shah,Michael R. Bishop,Olalekan O. Oluwole,Aaron C Logan,Maria R. Baer,William B. Donnellan,Kristen M. O'Dwyer,Houston Holmes,Martha Arellano,Armin Ghobadi,John M. Pagel,Yi Lin,Ryan D. Cassaday,Jae H. Park,Mehrdad Abedi,Januario E. Castro,Daniel J. DeAngelo,Adriana K. Malone,Raya Mawad,Gary J. Schiller,John M. Rossi,Adrian Bot,Tong Shen,Lovely Goyal,Rajul K. Jain,Remus Vezan,William G. Wierda +26 more
TL;DR: KTE-X19 treatment provided a high response rate and tolerable safety in adults with R/R B-ALL and revised adverse event (AE) management for CRS and NE was evaluated at 1×106 cells/kg KTE- X19, with overall complete remission rate correlated with CAR T-cell expansion.
Journal ArticleDOI
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
Areej El-Jawahri,Yi Bin Chen,Ruta Brazauskas,Naya He,Stephanie J. Lee,Jennifer M. Knight,Navneet S. Majhail,David Buchbinder,Raquel M. Schears,Baldeep Wirk,William A. Wood,Ibrahim Ahmed,Mahmoud Aljurf,Jeff Szer,Sara Beattie,Minoo Battiwalla,Christopher E. Dandoy,Miguel Angel Diaz,Anita D'Souza,Cesar O. Freytes,James Gajewski,Usama Gergis,Shahrukh K. Hashmi,Ann A. Jakubowski,Rammurti T. Kamble,Tamila L. Kindwall-Keller,Hillard M. Lazarus,Adriana K. Malone,David I. Marks,Kenneth R. Meehan,Bipin N. Savani,Richard F. Olsson,Richard F. Olsson,David A. Rizzieri,Amir Steinberg,Dawn Speckhart,David Szwajcer,Hélène Schoemans,Sachiko Seo,Celalettin Ustun,Yoshiko Atsuta,Jignesh Dalal,Carmem Sales-Bonfim,Nandita Khera,Theresa Hahn,Wael Saber +45 more
TL;DR: To evaluate the impact of depression before autologous and allogeneic hematopoietic cell transplantation (HCT) on clinical outcomes post‐transplantation, six patients with a history of depression were selected for HCT.
Journal ArticleDOI
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT.
David Buchbinder,Debra Lynch Kelly,Rafael F. Duarte,Jeffery J. Auletta,Neel S. Bhatt,Michael Byrne,Zachariah DeFilipp,Melissa Gabriel,Anuj Mahindra,Maxim Norkin,Hélène Schoemans,Ami J. Shah,Ibrahim Ahmed,Yoshiko Atsuta,Grzegorz W. Basak,Sara Beattie,Sita D. Bhella,Christopher Bredeson,Nancy Bunin,Jignesh Dalal,Andrew Daly,James Gajewski,Robert Peter Gale,John P. Galvin,Mehdi Hamadani,Robert J. Hayashi,Kehinde Adekola,Jason Law,Catherine J. Lee,Jane L. Liesveld,Adriana K. Malone,Arnon Nagler,Arnon Nagler,Seema Naik,Taiga Nishihori,Susan K. Parsons,Angela Scherwath,Hannah-Lise T. Schofield,Robert J. Soiffer,Jeff Szer,Ida Twist,Anne B. Warwick,Baldeep Wirk,Jean Yi,Minoo Battiwalla,M.E. Flowers,Bipin N. Savani,Bronwen E. Shaw +47 more
TL;DR: An expert review of neurocognitive dysfunction following HCT is reviewed to help clinicians understand the scope of this health-related problem, highlight its impact on well-being of survivors, and to help determine factors that may improve identification of patients at risk for declines in cognitive functioning after HCT.